Since joining PharmaVentures in 2011, Ping has played a key role in many successful deals, including the successful sale of the majority stake in Dogu Tip, a deal which he led.
Prior to joining PharmaVentures in 2011, he was principally with Morgan Stanley, Lazard and the Monitor Group. To date, Ping has worked on over 120 assignments and led or transacted over 30 completed deals with a total value of over $20 billion, advising global corporates, PE/VC firms, high growth companies and vendors of privately owned businesses. He is particularly experienced in cross-border deals (buyside and sellside) with extensive experience in Developed Markets and also in Emerging Markets, including China, India, Russia, Africa and Asia generally. Ping is also a specialist in discreet company sales that maximise the buyer base whilst preserving the utmost confidentiality.
Oxford educated, with an MBA from London Business School, Ping has over 18 years international M&A, corporate finance and strategy experience. For the last three years he has specialised within the life science and healthcare sectors.